Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | 0.00% | -4.57% | +7.74% |
Financials (USD)
Sales 2024 * | 103M | Sales 2025 * | 76.06M | Capitalization | 130M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -50M | EV / Sales 2024 * | 1.26 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
-11.8
x | P/E ratio 2025 * |
-3.53
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.97% |
Latest transcript on CytomX Therapeutics, Inc.
1 week | -4.57% | ||
Current month | -1.76% | ||
1 month | -62.30% | ||
3 months | -38.60% | ||
6 months | +18.44% | ||
Current year | +7.74% |
Managers | Title | Age | Since |
---|---|---|---|
Sean McCarthy
CEO | Chief Executive Officer | 57 | 10-11-30 |
Chris Ogden
DFI | Director of Finance/CFO | 40 | 21-08-01 |
Marcia Belvin
CTO | Chief Tech/Sci/R&D Officer | 57 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Meyers
BRD | Director/Board Member | 59 | 18-12-19 |
Elaine Jones
BRD | Director/Board Member | 69 | 14-11-30 |
Sean McCarthy
CEO | Chief Executive Officer | 57 | 10-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 1.67 | 0.00% | 3,501,288 |
24-06-05 | 1.67 | -0.60% | 2,103,372 |
24-06-04 | 1.68 | -4.00% | 1,619,818 |
24-06-03 | 1.75 | +2.94% | 1,247,477 |
24-05-31 | 1.7 | -2.86% | 953,744 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.74% | 130M | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |
- Stock Market
- Equities
- CTMX Stock